Pregnancy Intervention Revolving Around Goal-focused Education (GIRAFE) (GIRAFE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03984630|
Recruitment Status : Completed
First Posted : June 13, 2019
Last Update Posted : June 17, 2019
|Condition or disease||Intervention/treatment||Phase|
|Pregnancy||Behavioral: Dietary Fiber Intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||25 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Feasibility of a Single Goal Intervention to Promote Appropriate Gestational Weight Gain|
|Actual Study Start Date :||August 11, 2016|
|Actual Primary Completion Date :||February 9, 2017|
|Actual Study Completion Date :||April 20, 2017|
No Intervention: Control Arm
Participants were informed to continue to receive usual care by their Obstetrician and were asked to send in body weights weekly.
Experimental: Intervention Arm
Received snacks high in fiber, attended weekly phone calls, recorded daily food intake and reported weekly body weight for 12 weeks.
Behavioral: Dietary Fiber Intervention
Intervention included weekly group-based phone counseling with a Registered Dietitian (RD) to encourage consumption of a high fiber diet (≥30 g/day). All women reported their body weight weekly.
- Proportion of excessive gestational weight gain based on weight gain guidelines. [ Time Frame: 12-24 weeks gestation and during pregnancy ]
- Total gestational weight gain [ Time Frame: 12-24 weeks gestation and during pregnancy ]Measure gestational weight gain (kg) for those women in the intervention arm and control arm.
- Total dietary fiber intake [ Time Frame: 12-24 weeks gestation and during pregnancy ]≥30 g/day
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03984630
|Principal Investigator:||Holly Hull, PhD||The University of Kansas Medical Center|